Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17.89 USD | +2.23% | +6.74% | +59.73% |
May. 15 | B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating | MT |
May. 14 | Transcript : Harrow, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Evolution of the average Target Price on Harrow, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Harrow, Inc.
B. Riley | |
Craig-Hallum | |
Lake Street | |
Aegis Capital |
EPS Revisions
- Stock Market
- Equities
- HROW Stock
- Consensus Harrow, Inc.